SC 13D Filing

Company

ORAMED PHARMACEUTICALS INC.

Filed

June 10, 2004

Accession Number

0001288845-04-000008

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →